Stress amplifies lung tissue mechanics, inflammation and oxidative stress induced by chronic inflammation

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
EXPERIMENTAL LUNG RESEARCH, v.38, n.7, p.344-354, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Mechanisms linking behavioral stress and inflammation are poorly understood, mainly in distal lung tissue. Objective: We have investigated whether the forced swim stress (FS) could modulate lung tissue mechanics, iNOS, cytokines, oxidative stress activation, eosinophilic recruitment, and remodeling in guinea pigs (GP) with chronic pulmonary inflammation. Methods: The GP were exposed to ovalbumin or saline aerosols (2x/wk/4wks, OVA, and SAL). Twenty-four hours after the 4th inhalation, the GP were submitted to the FS protocol (5x/wk/2wks, SAL-S, and OVA-S). Seventy-two hours after the 7th inhalation, lung strips were cut and tissue resistance (Rt) and elastance (Et) were obtained (at baseline and after OVA and Ach challenge). Strips were submitted to histopathological evaluation. Results: The adrenals' weight, the serum cortisol, and the catecholamines were measured. There was an increase in IL-2, IL-5, IL-13, IFN-gamma, iNOS, 8-iso-PGF2 alpha, and in %Rt and %Et after Ach challenge in the SAL-S group compared to the SAL one. The OVA-S group has had an increase in %Rt and %Et after the OVA challenge, in %Et after the Ach and in IL-4, 8-iso-PGF2 alpha, and actin compared to the OVA. Adrenal weight and cortisol serum were increased in stressed animals compared to nonstressed ones, and the catecholamines were unaltered. Conclusion & clinical relevance: Repeated stress has increased distal lung constriction, which was associated with an increase of actin, IL-4, and 8-iso-PGF2 alpha levels. Stress has also induced an activation of iNOS, cytokines, and oxidative stress pathways.
Palavras-chave
cytokines, iNOS, isoprostane, lung distal tissue mechanics, stress
Referências
  1. Angeli P, 2008, AM J PHYSIOL-LUNG C, V294, pL1197, DOI 10.1152/ajplung.00199.2007
  2. Bailey MT, 2009, J IMMUNOL, V182, P7888, DOI 10.4049/jimmunol.0800891
  3. BOULOUX P, 1985, ANN CLIN BIOCHEM, V22, P194
  4. Briest W, 2003, CARDIOVASC RES, V57, P379, DOI 10.1016/S0008-6363(02)00700-9
  5. Capelozzi MA, 2007, RESP PHYSIOL NEUROBI, V156, P171, DOI 10.1016/j.resp.2006.09.004
  6. Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557
  7. Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009
  8. Chi DS, 2003, NITRIC OXIDE-BIOL CH, V8, P127, DOI 10.1016/S1089-8603(02)00148-9
  9. Fenske M, 1996, J EXP ANIM SCI, V38, P13
  10. Fernandes Lynette B, 2007, Ther Adv Respir Dis, V1, P25, DOI 10.1177/1753465807080740
  11. Forsythe P, 2004, AM J RESP CRIT CARE, V169, P220, DOI 10.1164/rccm.200307-979OC
  12. Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0
  13. Lancas T, 2006, J APPL PHYSIOL, V100, P1610, DOI 10.1152/japplphysiol.00828.2005
  14. Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004
  15. Mauad T, 2004, AM J RESP CRIT CARE, V170, P857, DOI 10.1164/rccm.200403-305OC
  16. Miller M, 2006, AM J PHYSIOL-LUNG C, V290, pL162, DOI 10.1152/ajplung.00252.2005
  17. Nittoh T, 1998, EUR J PHARMACOL, V354, P73, DOI 10.1016/S0014-2999(98)00426-9
  18. Okuyama Kaori, 2007, Allergol Int, V56, P29, DOI 10.2332/allergolint.O-06-435
  19. Portela CD, 2002, AM J PHYSIOL-LUNG C, V282, pL1289, DOI 10.1152/ajplung.00352.2001
  20. Prado CM, 2006, AM J RESP CELL MOL, V35, P457, DOI 10.1165/rcmb.2005-0391OC
  21. Sivonova M, 2004, STRESS, V7, P183, DOI 10.1080/10253890400012685
  22. Starling CM, 2009, RESP PHYSIOL NEUROBI, V165, P185, DOI 10.1016/j.resp.2008.11.011
  23. Tiberio Iolanda F. L. C., 2003, Experimental Lung Research, V29, P165, DOI 10.1080/01902140303772
  24. Torres RL, 2004, BRAZ J MED BIOL RES, V37, P185
  25. Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S
  26. Vieira RP, 2007, AM J RESP CELL MOL, V37, P660, DOI 10.1165/rcmb.2007-01080C
  27. Vig RS, 2006, ANN NY ACAD SCI, V1088, P65, DOI 10.1196/annals.1366.023
  28. Viveros-Paredes JM, 2006, INT IMMUNOPHARMACOL, V6, P774, DOI 10.1016/j.intimp.2005.11.011
  29. Wicke KM, 2007, PSYCHOPHARMACOLOGY, V195, P95, DOI 10.1007/s00213-007-0874-0
  30. Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006
  31. Xisto DG, 2005, AM J RESP CRIT CARE, V171, P829, DOI 10.1164/rccm.200408-997OC
  32. Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496
  33. Zhang HY, 1999, AM J RESP CELL MOL, V21, P658